Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ACLC 2018
IASLC Asia Conference on Lung Cancer 2018
Access Abstracts and Powerpoint Slides to select presentations that took place during the IASLC Asia Conference on Lung Cancer 2018 in Guangzhou, China from November 8 - 10, 2018. This package is available for no charge to active IASLC Members.
Presentation Date(s):- November 8 - 10, 2018
- Total Presentations: 137
-
+
Poster Session
- Type: Poster Session
- Track:
- Presentations: 90
- Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall
-
+
P001 - Discrepancy of Oncogenic Mutations in Bone Metastasis Derived from Lung Adenocarcinoma
00:00 - 00:00 | Author(s): L. Huang
- Abstract
Loading... -
+
P002 - Surgical Resection Improves the Survival of
00:00 - 00:00 | Author(s): B. Zhang
- Abstract
Loading... -
+
P003 - Prognosis of Advanced Lung Cancer by Age Groups : A SEER Database Analysis
00:00 - 00:00 | Author(s): B. Wang
- Abstract
Loading... -
+
P006 - Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Small Lung Nodule
00:00 - 00:00 | Author(s): C. Zhang
- Abstract
Loading... -
+
P008 - Correlation Between Genetic Mutation State and Cancer-Associated Thrombosis in Advanced Cancer Patients
00:00 - 00:00 | Author(s): X. Zhang
- Abstract
Loading... -
+
P011 - Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy
00:00 - 00:00 | Author(s): D. Wu
- Abstract
Loading... -
+
P012 - Pooled Safety Analysis for Two Generations ALK Inhibitors: A Meta Analysis
00:00 - 00:00 | Author(s): D. Sun
- Abstract
Loading... -
+
P013 - Anti-PD-1 Combination
00:00 - 00:00 | Author(s): F. Zhang
- Abstract
Loading... -
+
P015 - Motion Management Without Fiducial Tracking Using Cyberknife SBRT
00:00 - 00:00 | Author(s): G. Lohith
- Abstract
Loading... -
+
P016 - The Optimal ALK inhibitor in Advanced ALK-Positive NSCLC Patients: An Indirect Comparison Between Brigatinib and Alectinib
00:00 - 00:00 | Author(s): H Zhou
- Abstract
Loading... -
+
P017 - Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): G. Wang
- Abstract
Loading... -
+
P018 - Afatinib Named Patient Use Program in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers
00:00 - 00:00 | Author(s): G. Chang
- Abstract
Loading... -
+
P020 - Characterization of Met Exon 14 Skipping and Association with Clinical Outcomes of Crizotinib in Chinese Lung Cancers
00:00 - 00:00 | Author(s): H. Yang
- Abstract
Loading... -
+
P021 - The Impact of TP53 Mutation and Tumor Mutation Number on Outcomes in Patients with Stage I Non
00:00 - 00:00 | Author(s): S. Zheng
- Abstract
Loading... -
+
P022 - Association Between Oral Leukoplakia and Lung Cancer: A 28-Year Follow-Up Study in the Linxian General Population Trial
00:00 - 00:00 | Author(s): H. Liang
- Abstract
Loading... -
+
P023 - Factors associated with administration of subsequent cytotoxic chemotherapy after nivolumab in patients with advanced NSCLC
00:00 - 00:00 | Author(s): H. Jo
- Abstract
Loading... -
+
P024 - Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Experience of a Single Institute
00:00 - 00:00 | Author(s): H. Liu
- Abstract
Loading... -
+
P025 - Which Is the Optimal Immunotherapy for Advanced Non-Squamous Non-Small-Cell Lung Cancer in Combination with Chemotherapy?
00:00 - 00:00 | Author(s): H Zhou
- Abstract
Loading... -
+
P026 - Impact of Prior Cancer History on the Overall Survival of Younger Patients with Lung Cancer
00:00 - 00:00 | Author(s): H. Zhou
- Abstract
Loading... -
+
P028 - A Novel Method for Detecting Surface PD-L1 on Circulating Tumor Cells in Peripheral Blood of Patients with SCLC
00:00 - 00:00 | Author(s): D. Zhao
- Abstract
Loading... -
+
P029 - Circulating MDSCs Derived from Small Cell Lung Cancer Patients Secrete TGF - Beta 1 and Play Roles in Angiogenesis
00:00 - 00:00 | Author(s): S. Lan
- Abstract
Loading... -
+
P030 - Prognostic Factors for Advanced Lung Adenocarcinoma Patients Who Received Tyrosine Kinase Inhibitor and Radiotherapy
00:00 - 00:00 | Author(s): H. Yang
- Abstract
Loading... -
+
P032 - Integrin Subunit Alpha 5: Potential Prognostic Biomarker in Lung Adenocarcinoma
00:00 - 00:00 | Author(s): J.H. Hong
- Abstract
Loading... -
+
P033 - A Fusion-Protein Approach Enabling Mammalian Cell Production of Tumor Targeting Protein Domains for Therapeutic Development
00:00 - 00:00 | Author(s): J. Hu
- Abstract
Loading... -
+
P034 - A Case of Stage IIIA Thymoma Underwent Thymectomy with the Subxiphoid Approach
00:00 - 00:00 | Author(s): B. Aramini
- Abstract
Loading... -
+
P036 - Rechallenge Pemetrexed-Based Chemotherapy Provides an
00:00 - 00:00 | Author(s): J. Wang
- Abstract
Loading... -
+
P037 - QSOX1/2 Regulates
00:00 - 00:00 | Author(s): Y. Li
- Abstract
Loading... -
+
P038 - Docosapentaenoic Acid and Lung Cancer Risk: A Mendelian Randomisation Study
00:00 - 00:00 | Author(s): J. Liu
- Abstract
Loading... -
+
P039 - Clinical Characteristics and Survival of Patients with Lymphoepithelioma-Like Carcinoma in Lung and Bronchus and Other Sites
00:00 - 00:00 | Author(s): J. Liu
- Abstract
Loading... -
+
P040 - Highly Sensitivity and Fast Genetic Diagnosis by Mean of a Novel NGS-Based Resequencing Gene Panel Underlying SCLC Patients
00:00 - 00:00 | Author(s): J. Wang
- Abstract
Loading... -
+
P041 - Different Recurrence Models in Lung Cancer Patients Between
00:00 - 00:00 | Author(s): J. Xia
- Abstract
Loading... -
+
P042 - LincRNA00494 Suppresses Non-Small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression in A ceRNA Manner
00:00 - 00:00 | Author(s): J. Dong
- Abstract
Loading... -
+
P043 - Cost-Effectiveness Analysis of Different Sequences of Osimertinib Administration for EGFR-Mutated Non-Small-Cell Lung Cancer
00:00 - 00:00 | Author(s): W. Li
- Abstract
Loading... -
+
P044 - Cost-Effectiveness Analysis of Icotinib vs Whole-Brain Irradiation in NSCLC Patients with Brain Metastases
00:00 - 00:00 | Author(s): W. Li
- Abstract
Loading... -
+
P045 - Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients with Surgically Resected Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): X. Ding
- Abstract
Loading... -
+
P047 - Clinical Characteristics of the Surviving Lung Cancer Patients at Shanghai Chest Hospital During 2007- 2017
00:00 - 00:00 | Author(s): Y. Zhao
- Abstract
Loading... -
+
P049 - Neurocognitive Functions Before Radiotherapy for Brain Metastasis from Lung Cancer: An Analysis of 74 Cases
00:00 - 00:00 | Author(s): J. Zhen
- Abstract
Loading... -
+
P050 - Long-Term Survival of Stage IIIA-N2 NSCLC Patients with Interstitial Lung Diseases
00:00 - 00:00 | Author(s): J. Watanabe
- Abstract
Loading... -
+
P051 - A Novel
00:00 - 00:00 | Author(s): K. Yin
- Abstract
Loading... -
+
P052 - A Biomarker Study of Advanced Non-Small Cell Lung Cancer Using Ultra-High-Performance Liquid Chromatography-Mass Spectrometry
00:00 - 00:00 | Author(s): K. Zhang
- Abstract
Loading... -
+
P053 - The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel
00:00 - 00:00 | Author(s): K. Zhang
- Abstract
Loading... -
+
P054 - Applicability of the Lung-molGPA Index in NSCLC
00:00 - 00:00 | Author(s): K. Chen
- Abstract
Loading... -
+
P057 - Pembrolizumab +
00:00 - 00:00 | Author(s): K.F. Ang
- Abstract
Loading... -
+
P058 - Effects of Neoadjuvant Chemotherapy on the Expression
00:00 - 00:00 | Author(s): W. Sun
- Abstract
Loading... -
+
P061 - Real Clinical Practice of Using Immunotherapy In NSCLC Patients With EGFR Mutation
00:00 - 00:00 | Author(s): L. Shen
- Abstract
Loading... -
+
P063 - STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma
00:00 - 00:00 | Author(s): L. Huang
- Abstract
Loading... -
+
P066 - A Phase I Study of Apatinib Combined with Pemetrexed and Carboplatin in Untreated EGFR-Negative Stage IV Non-Squamous NSCLC
00:00 - 00:00 | Author(s): M. Huang
- Abstract
Loading... -
+
P068 - The Geriatric Nutritional Risk Index Predicts the Overall Survival in Geriatric Patients with Metastatic Lung Adenocarcinoma
00:00 - 00:00 | Author(s): M. Tang
- Abstract
Loading... -
+
P069 - HOTAIR, A Long Non-Coding RNA, Is a Marker of Abnormal Cell Cycle Regulation in Lung Cancer
00:00 - 00:00 | Author(s): M. Liu
- Abstract
Loading... -
+
P070 - Pembrolizumab for Non-Small Cell Lung Cancer with Untreated Central Nervous System Metastases: A Case Report
00:00 - 00:00 | Author(s): M. Di
- Abstract
Loading... -
+
P071 - Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers
00:00 - 00:00 | Author(s): N. Liang
- Abstract
Loading... -
+
P072 - Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by
00:00 - 00:00 | Author(s): O. Yuko
- Abstract
Loading... -
+
P073 - Cbl-b Predicts Prognosis of NSCLC Patients and Affects PD-L1 Expression in A549
00:00 - 00:00 | Author(s): P. Li
- Abstract
Loading... -
+
P075 - Hippo-YAP Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer
00:00 - 00:00 | Author(s): P. Sun
- Abstract
Loading... -
+
P076 - A Lung Adenocarcinoma with Concomitant EGFR And De Novo MET Amplification Response Well to Combination of TKI And Bevacizumab
00:00 - 00:00 | Author(s): Q. Chu
- Abstract
Loading... -
+
P077 - miR-338-3p Promotes the Resistance of Non-Small Cell Lung Cancers To EGFR-TKI By Targeting PTPN12
00:00 - 00:00 | Author(s): Q. Wu
- Abstract
Loading... -
+
P080 - Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients with Advanced NSCLC
00:00 - 00:00 | Author(s): S. Yokota
- Abstract
Loading... -
+
P081 - Clinical Characteristics and Molecular Patterns Of RET-Rearranged Lung Cancer in Chinese Patients
00:00 - 00:00 | Author(s): S. Fei
- Abstract
Loading... -
+
P082 - DNA Methylation: A More Sensitive Marker for Treatment Monitoring?
00:00 - 00:00 | Author(s): S. Xia
- Abstract
Loading... -
+
P083 - Efficacy of EGFR-TKIs in Patients Harboring EGFR Mutations with Non-Adenocartinoma Histology
00:00 - 00:00 | Author(s): O Yuko
- Abstract
Loading... -
+
P084 - Musashi-2 Expression Is an
00:00 - 00:00 | Author(s): T. Wang
- Abstract
Loading... -
+
P086 - Toward the Standardization of Bioinformatics Methods for the Accurate Assessment of Tumor Mutational Burden (TMB)
00:00 - 00:00 | Author(s): H. Chang
- Abstract
Loading... -
+
P087 - TNM Staging Inversely Correlates with Age in ALK-positive Lung Cancer
00:00 - 00:00 | Author(s): W. Tang
- Abstract
Loading... -
+
P088 - Distribution of Different HER2 Mutations
00:00 - 00:00 | Author(s): W Wang
- Abstract
Loading... -
+
P089 - An EGFR KDD Data in the Chinese NSCLC Population and the Response to EGFR-TKIs: A Multicenter Study
00:00 - 00:00 | Author(s): W. Wang
- Abstract
Loading... -
+
P090 - Prevalence of Brain Metastases in Limited Stage Small Cell Lung Cancer Immediately Before Prophylactic Cranial Irradiation
00:00 - 00:00 | Author(s): X. Chu
- Abstract
Loading... -
+
P091 - Association Between BIM Polymorphism and Lung Cancer Outcomes: A Meta-analysis
00:00 - 00:00 | Author(s): X. Li
- Abstract
Loading... -
+
P093 - DNA Methylation in CTC And ctDNA is A Promising Marker for Early Detection of Lung Cancer Metastasis
00:00 - 00:00 | Author(s): X. Qiu
- Abstract
Loading... -
+
P094 - Evaluation of the Efficacy of Salvage Surgery for Advanced NSCLC Patients After Neoadjuvant
00:00 - 00:00 | Author(s): X. Cao
- Abstract
Loading... -
+
P095 - MicroRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer by Activating MAPK/MEK/ERK Signaling Through GRIA3
00:00 - 00:00 | Author(s): C. Wei
- Abstract
Loading... -
+
P096 - MLPH Activates CDC42/PAK1 Signaling to Promote Epithelial
00:00 - 00:00 | Author(s): C. Wei
- Abstract
Loading... -
+
P097 - ctDNA Changes and TCR Diversity Associated with Clinical Outcomes Following Brain Therapy in NSCLC
00:00 - 00:00 | Author(s): C. Wei
- Abstract
Loading... -
+
P100 - Stem Cell Factor Leads to Lung Cancer Escapes from Anti-Angiogenic Therapy by Increasing the ALDH1+ Lung Cancer Cell Number
00:00 - 00:00 | Author(s): Y. Liu
- Abstract
Loading... -
+
P101 - Intratumor Heterogeneity Comparison Among Different Subtypes of
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P102 - The Correlations of Tumor Mutational Burden Among Single-region Tissue, Multi-region Tissues And Blood in NSCLC
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P104 - Anti-PD-1 Combination Therapy in Second or Later Lines in
00:00 - 00:00 | Author(s): F. Zhang
- Abstract
Loading... -
+
P105 - Computational Design of IgG-like Tetra-specific Antibody Targeting EGFR/VEGF/PD-1/CTLA-4 Against NSCLC
00:00 - 00:00 | Author(s): Y. Hu
- Abstract
Loading... -
+
P106 - The Efficacy and Safety of Bevacizumab Combined with Chemotherapy in the Treatment of Drug-Resistant SCLC
00:00 - 00:00 | Author(s): X. Liu
- Abstract
Loading... -
+
P107 - The Study of Relationship Between Tumor Burden (TMB) and Molecular Typing of Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Author(s): R. Zhong
- Abstract
Loading... -
+
P109 - Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients with Sensitive Relapsed SCLC
00:00 - 00:00 | Author(s): L. Zhang
- Abstract
Loading... -
+
P111 - Circulating Tumor Cells Combined Myeloid Derived Suppressor Cells Predict Prognosis of Advanced Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Y. Liu
- Abstract
Loading... -
+
P112 - Significance of Low Expression of Tumor Associated Gene ki67 in Recurrence of Small Cell Lung Cancer
00:00 - 00:00 | Author(s): X. Zhang
- Abstract
Loading... -
+
P113 - Icotinib Alone or with Radio Therapy Inpatients with EGFR Mutations Non-Small Cell Lung Cancer Who Develop Brain Metastases
00:00 - 00:00 | Author(s): Y. Xin
- Abstract
Loading... -
+
P114 - Whole-Exome Sequencing
00:00 - 00:00 | Author(s): Y. Xu
- Abstract
Loading... -
+
P115 - Clinical Outcome of Crizotinib in Diverse ALK Fusion Partners and Different Detection Methods Treatment Na
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P116 - Real World Data of 1st Line A+T in Advanced EGFR+ NSCLC: Clinical Outcome, PFS Influential Factors and Acquired Resistance
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P117 - MET 14 Skipping Mutation in Pulmonary Sarcomatoid Carcinoma Using Reverse Transcription Polymerase Chain Reaction Method
00:00 - 00:00 | Author(s): Y. Zhu
- Abstract
Loading... -
+
P119 - Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study
00:00 - 00:00 | Author(s): Y. Zheng
- Abstract
Loading... -
+
P120 - How to Become Exsomes As Messengers and Sentinels to Influence Lung Cancer Growing?
00:00 - 00:00 | Author(s): Z. Yu
- Abstract
Loading... -
+
P121 - Clinical Value of Local Therapy in Advanced Crizotinib-Treated ALK-Rearranged Lung Cancer: Pattern of Failure Analyses
00:00 - 00:00 | Author(s): J. Ni
- Abstract
Loading...
-
+
Best abstracts selected from submissions 1
- Type: Oral Session
- Track:
- Presentations: 2
- Coordinates: 11/08/2018, 10:55 - 11:30, Crystal Ballroom
-
+
OA01 - LKB1 Pathway Variant TSC2 rs30259 Predicts the Prognosis in Early Stage Non-Small Cell Lung Cancer
00:55 - 01:05 | Author(s): S.K. Do
- Abstract
Loading... -
+
OA02 - Targeted Next-Generation Sequencing Reveals Relapse-Associated Genomic Alterations in Early Stage Non-Small Cell Lung Cancer
01:05 - 01:15 | Author(s): W. Cho
- Abstract
Loading...
-
+
Best abstracts selected from submissions 2
- Type: Oral Session
- Track:
- Presentations: 2
- Coordinates: 11/08/2018, 16:20 - 17:00, Jade Ballroom
-
+
OA03 - Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
06:20 - 06:30 | Author(s): M.J. Hochmair
- Abstract
Loading... -
+
OA04 - Factors Influencing the Non-Administration of Chemotherapies in Patients Who Progressed After
06:30 - 06:40 | Author(s): T. Mizuno
- Abstract
Loading...
-
+
Best abstracts selected from submissions 3
- Type: Oral Session
- Track:
- Presentations: 2
- Coordinates: 11/08/2018, 16:20 - 17:00, Crystal Ballroom 1
-
+
OA05 - Tumor Mutational Burden Standardization Initiative: Establish a Consistent Methodology for TMB Measurement in Clinical Samples
06:20 - 06:30 | Author(s): F Yan
- Abstract
Loading... -
+
OA06 - Tepotinib in Non-Small Cell Lung Cancer with MET Exon 14-Skipping Mutations or MET Amplification:
06:30 - 06:40 | Author(s): P. Paik
- Abstract
Loading...
-
+
Parallel Session 1 - Biomarker detecting for lung cancer: new technique and new opinion
- Type: Oral Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 11/08/2018, 16:20 - 17:00, Jade Ballroom
-
+
What is a trustworthy biomarker? (Slides Available)
04:25 - 04:50 | Author(s): C Manegold
- Abstract
No abstract available for this presentation
-
+
Standardization of molecular testing in China (Slides Available)
04:50 - 05:15 | Author(s): X Zhang
- Abstract
No abstract available for this presentation
-
+
Discussant - Sequencing or Combination? (Slides Available)
06:40 - 07:00 | Author(s): J Hu
- Abstract
No abstract available for this presentation
-
+
Parallel Session 2 - Brain metastases and Leptomeningeal metastasis
- Type: Oral Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 11/08/2018, 16:20 - 17:00, Crystall Ballroom 1
-
+
Diagnosis and management of leptomeningeal metastasis (Slides Available)
05:15 - 05:40 | Author(s): J Yang
- Abstract
No abstract available for this presentation
-
+
Optimal radiotherapy for CNS metastasis in patients with a driver oncogene (Slides Available)
20:25 - 20:50 | Author(s): Y Lu
- Abstract
No abstract available for this presentation
-
+
Can this drug penetrate the brain? (Slides Available)
20:50 - 21:15 | Author(s): F Kong
- Abstract
No abstract available for this presentation
-
+
Parallel Session 3 - Tobacco control, Staging and cancer prevention in Asia
- Type: Oral Session
- Track:
- Presentations: 1
- Slides Available
- Coordinates: 11/08/2018, 16:20 - 17:00, Crystall Ballroom 3
-
+
Tobacco control in China (Slides Available)
04:00 - 04:20 | Author(s): X Zhi
- Abstract
No abstract available for this presentation
-
+
Plenary Session - Past, Present and Future of Targeted Therapy in NSCLC
- Type: Oral Session
- Track:
- Presentations: 3
- Slides Available
- Coordinates: 11/08/2018, 16:20 - 17:00, Crystal Ballroom
-
+
Optimal sequence of EGFR TKI (Slides Available)
08:15 - 08:40 | Author(s): T Mok
- Abstract
No abstract available for this presentation
-
+
Clinical application of ctDNA in management of oncogenic driven lung cancer (Slides Available)
09:05 - 09:30 | Author(s): S Lu
- Abstract
No abstract available for this presentation
-
+
Optimal sequence of ALK TKI (Slides Available)
08:40 - 09:05 | Author(s): I Ou
- Abstract
No abstract available for this presentation
-
+
Best abstracts selected from submissions 4
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 10:50 - 11:30, Crystal Ballroom
-
+
OA07 - Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers (Slides Available)
16:50 - 17:00 | Author(s): Z. Liu
- Abstract
Loading... -
+
OA08 - Efficacy and Safety of Sintilimab Combined with 1st Line Chemotherapy in Advanced Squamous Cell Non-small Cell Lung Cancer (Slides Available)
17:00 - 17:10 | Author(s): K. Ying
- Abstract
Loading...
-
+
Best abstracts selected from submissions 5
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 16:20 - 17:00, Crystal Ballroom 1
-
+
OA09 - Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer (Slides Available)
22:20 - 22:30 | Author(s): S. Ou
- Abstract
Loading... -
+
OA10 - CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)
06:30 - 06:40 | Author(s): Y. Wu
- Abstract
Loading...